Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Recommendation of “Hold” by Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been given an average recommendation of “Hold” by the eighteen analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and five have given a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $7.5313.

Several research firms have recently weighed in on TDOC. TD Cowen cut their target price on Teladoc Health from $8.00 to $6.00 and set a “hold” rating on the stock in a research report on Thursday, February 26th. Piper Sandler reissued an “overweight” rating and set a $9.00 target price (down from $12.00) on shares of Teladoc Health in a research report on Thursday, February 26th. Barclays cut their target price on Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating on the stock in a research report on Thursday, March 26th. Oppenheimer cut their target price on Teladoc Health from $12.00 to $7.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 3rd. Finally, Deutsche Bank Aktiengesellschaft raised Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a research report on Tuesday, March 10th.

Insider Transactions at Teladoc Health

In related news, CEO Charles Divita III sold 27,731 shares of the business’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $5.49, for a total transaction of $152,243.19. Following the completion of the transaction, the chief executive officer owned 364,784 shares in the company, valued at $2,002,664.16. The trade was a 7.06% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently bought and sold shares of TDOC. EverSource Wealth Advisors LLC boosted its holdings in Teladoc Health by 694.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 4,945 shares during the period. PNC Financial Services Group Inc. boosted its holdings in Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 2,810 shares during the period. IFP Advisors Inc boosted its holdings in Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 3,210 shares during the period. Aster Capital Management DIFC Ltd boosted its holdings in Teladoc Health by 101.1% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after acquiring an additional 2,425 shares during the period. Finally, International Assets Investment Management LLC purchased a new position in Teladoc Health during the 4th quarter valued at $45,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

NYSE:TDOC opened at $6.59 on Friday. The company has a market cap of $1.19 billion, a price-to-earnings ratio of -6.79 and a beta of 2.08. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72. The stock’s 50 day simple moving average is $5.85 and its two-hundred day simple moving average is $6.25. Teladoc Health has a 1 year low of $4.40 and a 1 year high of $9.77.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.01). The company had revenue of $613.85 million for the quarter, compared to the consensus estimate of $611.04 million. Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The business’s revenue for the quarter was down 2.5% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.53) EPS. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. As a group, equities analysts anticipate that Teladoc Health will post -0.91 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.